2A20 image
Deposition Date 2005-06-21
Release Date 2005-08-16
Last Version Date 2024-05-22
Entry Detail
PDB ID:
2A20
Title:
Solution structure of Rim2 Zinc Finger Domain
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Conformers Calculated:
500
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Regulating synaptic membrane exocytosis protein 2
Gene (Uniprot):Rims2
Chain IDs:A
Chain Length:62
Number of Molecules:1
Biological Source:Rattus norvegicus
Ligand Molecules
Primary Citation
A Munc13/RIM/Rab3 tripartite complex: from priming to plasticity?
Embo J. 24 2839 2850 (2005)
PMID: 16052212 DOI: 10.1038/sj.emboj.7600753

Abstact

alpha-RIMs and Munc13s are active zone proteins that control priming of synaptic vesicles to a readily releasable state, and interact with each other via their N-terminal sequences. The alpha-RIM N-terminal sequence also binds to Rab3s (small synaptic vesicle GTPases), an interaction that regulates presynaptic plasticity. We now demonstrate that alpha-RIMs contain adjacent but separate Munc13- and Rab3-binding sites, allowing formation of a tripartite Rab3/RIM/Munc13 complex. Munc13 binding is mediated by the alpha-RIM zinc-finger domain. Elucidation of the three-dimensional structure of this domain by NMR spectroscopy facilitated the design of a mutation that abolishes alpha-RIM/Munc13 binding. Selective disruption of this interaction in the calyx of Held synapse decreased the size of the readily releasable vesicle pool. Our data suggest that the ternary Rab3/RIM/Munc13 interaction approximates synaptic vesicles to the priming machinery, providing a substrate for presynaptic plasticity. The modular architecture of alpha-RIMs, with nested binding sites for Rab3 and other targets, may be a general feature of Rab effectors that share homology with the alpha-RIM N-terminal sequence.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback